Total Payments
$3,951
2024 Payments
$1,237
Companies
20
Transactions
154
Medicare Patients
3,774
Medicare Billing
$177,876
Payment Breakdown by Category
Food & Beverage$3,934 (99.6%)
Education$17.40 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,934 | 151 | 99.6% |
| Education | $17.40 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,329 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $481.41 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $309.05 | 13 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $294.99 | 10 | $0 (2024) |
| PFIZER INC. | $274.39 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $273.73 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $256.95 | 17 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $135.63 | 4 | $0 (2024) |
| Esperion Therapeutics, Inc. | $120.29 | 2 | $0 (2023) |
| Kiniksa Pharmaceuticals International, plc | $104.36 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,237 | 56 | AstraZeneca Pharmaceuticals LP ($253.16) |
| 2023 | $1,259 | 46 | AstraZeneca Pharmaceuticals LP ($402.55) |
| 2022 | $829.82 | 35 | AstraZeneca Pharmaceuticals LP ($355.59) |
| 2021 | $624.84 | 17 | AstraZeneca Pharmaceuticals LP ($317.52) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Not Applicable | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.15 | General |
| 11/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | PFIZER INC. | VYNDAMAX (Drug) | Education | In-kind items and services | $3.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $11.39 | General |
| 10/14/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Not Applicable | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $95.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Not Applicable | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| Category: Cardiovascular | ||||||
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $113.74 | General |
| Category: DIABETES | ||||||
| 08/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 08/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.32 | General |
| 08/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Cardio-renal | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 242 | 347 | $58,990 | $19,322 |
| 2022 | 2 | 163 | 250 | $43,254 | $14,586 |
| 2021 | 15 | 1,979 | 10,463 | $595,453 | $92,340 |
| 2020 | 2 | 1,390 | 7,860 | $282,072 | $51,628 |
Total Patients
3,774
Total Services
18,920
Medicare Billing
$177,876
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 242 | 347 | $58,990 | $19,322 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 237 | $40,290 | $13,651 | 33.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 13 | $2,964 | $934.68 | 31.5% |
| 93793 | Anti-clotting management for patient taking warfarin | Facility | 2021 | 430 | 4,645 | $92,900 | $28,851 | 31.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 98 | 247 | $33,345 | $15,570 | 46.7% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2021 | 149 | 400 | $124,200 | $15,497 | 12.5% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2021 | 292 | 1,800 | $36,000 | $10,543 | 29.3% |
| 85610 | Blood test, clotting time | Office | 2021 | 298 | 1,956 | $165,282 | $8,354 | 5.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 152 | 409 | $69,121 | $3,447 | 5.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 25 | $4,750 | $2,337 | 49.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 42 | 44 | $3,960 | $1,820 | 46.0% |
| 83735 | Magnesium level | Office | 2021 | 122 | 266 | $21,147 | $1,747 | 8.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 150 | 412 | $13,287 | $1,236 | 9.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 67 | 94 | $11,327 | $730.38 | 6.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 36 | 38 | $9,937 | $626.85 | 6.3% |
| 93264 | Remote monitoring of wireless pressure sensor in lung artery with qualified health care professional analysis, review, and report | Facility | 2021 | 22 | 23 | $1,955 | $523.94 | 26.8% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 34 | 34 | $4,709 | $449.79 | 9.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 35 | 36 | $2,538 | $318.52 | 12.6% |
| 83550 | Iron binding capacity | Office | 2021 | 34 | 34 | $994.50 | $288.42 | 29.0% |
| 93793 | Anti-clotting management for patient taking warfarin | Facility | 2020 | 444 | 3,191 | $63,820 | $23,808 | 37.3% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2020 | 614 | 2,733 | $54,660 | $19,541 | 35.8% |
| 85610 | Blood test, clotting time | Office | 2020 | 332 | 1,936 | $163,592 | $8,280 | 5.1% |
About Angela Cheves, APRN, FNP-C
Angela Cheves, APRN, FNP-C is a Family healthcare provider based in North Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2019. The National Provider Identifier (NPI) number assigned to this provider is 1013560655.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Angela Cheves, APRN, FNP-C has received a total of $3,951 in payments from pharmaceutical and medical device companies, with $1,237 received in 2024. These payments were reported across 154 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,934).
As a Medicare-enrolled provider, Cheves has provided services to 3,774 Medicare beneficiaries, totaling 18,920 services with total Medicare billing of $177,876. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location North Little Rock, AR
- Active Since 07/23/2019
- Last Updated 11/11/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1013560655
Products in Payments
- FARXIGA (Drug) $1,140
- XARELTO (Drug) $481.41
- JARDIANCE (Drug) $309.05
- VERQUVO (Drug) $273.73
- Inpefa (Drug) $232.20
- VYNDAQEL (Drug) $181.03
- LEQVIO (Drug) $178.05
- LifeVest (Device) $135.63
- NEXLIZET (Drug) $105.73
- Arcalyst (Drug) $104.36
- BRILINTA (Drug) $100.01
- ELIQUIS (Drug) $90.16
- ANDEXXA (Biological) $88.44
- ONPATTRO (Drug) $80.54
- ENTRESTO (Drug) $78.90
- Kerendia (Drug) $71.17
- Hillrom - Cardiac Ambulatory Monitor (Device) $54.64
- Vascepa (Drug) $22.14
- ZIO XT Patch (Device) $19.36
- AMVUTTRA (Drug) $18.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in North Little Rock
Kimberly Gates, Aprn, APRN
Family — Payments: $16,977
Family $16,977
Morgan Hayes, Aprn, APRN
Family — Payments: $5,750
Family $5,750
Jessica Morrow, Aprn, APRN
Family — Payments: $3,351
Family $3,351
Kaelyn Lay, Msn, Aprn, MSN, APRN
Family — Payments: $2,651
Family $2,651
Kristin Green, Fnp-C, FNP-C
Family — Payments: $2,384
Family $2,384
Mrs. Lydia Williams, Aprn, APRN
Family — Payments: $2,033
Family $2,033